Skip to content
Back to Feed
Pre-Seed

SOLASTA Bio secures £4m pre-Series A funding led by Yield Lab Europe to scale eco-friendly insecticides.

Yield Lab Europe led the pre-Series A round, which will fund international expansion and team growth.

£4.0MPre-Seed

Share allotment filed at Companies House

SOLASTA Bio develops nature-inspired peptide-based insecticides designed to protect crops while preserving pollinators.

SOLASTA Bio has secured £4m in pre-Series A funding to scale its operations in the UK and US, expand its technical and commercial teams, and accelerate technology development. The round was led by Yield Lab Europe, with participation from Rubio Impact Ventures, Scottish Enterprise, Cavallo Ventures, SIS Ventures, UKI2S, and private agritech investors. Additional backing was provided by Innovate UK and Scottish Enterprise. The Glasgow University spinout develops neuropeptide-based insect control products to target pests safely and sustainably, aiming to bring its first products to market by 2027.


From the founder

"We’ve spent the past 18 months developing our platform and validating peptide candidates with expert third parties and commercial partners. We’re really excited by the results and feel that we’re ready to take the next step towards commercialising our technology. With the issue of food security, and effective crop protection becoming an increasingly pressing issue for the agriculture industry and governments worldwide, there is an urgent need for sustainable environmentally-friendly alternatives to current synthetic pesticides. We’re confident that our technology provides the solution and has the potential to make a huge impact."
SD

Shireen Davies

CEO at SOLASTA Bio


Investor perspective

"SOLASTA is a terrific example of how breakthroughs in science and academia can be brought to bear on the world’s grand challenges and build the high-growth businesses of the future."
KS

Kerry Sharp

Director of Entrepreneurship and Investment, Scottish Enterprise


Use of funds

  1. 01Expand into international markets
  2. 02Grow the team
  3. 03Continue product development

Investors

YL

Yield Lab Europe

RI

Tijl Hoefnagels

Rubio Impact Ventures

Scottish Enterprise

Kerry Sharp

Scottish Enterprise

CV

Brett Morris

Cavallo Ventures

SIS Ventures

SIS Ventures

UKI2S

Oliver Sexton

UKI2S


Categories

BioTech

About the company

SB

SOLASTA Bio

SOLASTA Bio develops green peptide-based insecticides for agricultural use.

United Kingdom Founded 2020
£18.0MRaised